\begin{tabular}{l*{4}{c}}
\hline\hline
            Variable&\multicolumn{1}{c}{Time frame}&\multicolumn{1}{c}{Total}&\multicolumn{1}{c}{Weighted Share of Sample}\\
\hline
\textbf{OffLabel}                                                &     Entire Study&             387264&      .967\\
(=1 if no diagnoses made were FDA approved          &     Before Entry of Generic&    223267&      .966\\
indications of sulfamethoxazole-trimethoprim)  &     After Entry of Generic&      163997&      .968\\
[1em]
\textbf{GovInsurance}                                            &     Entire Study&             105273&      .26 \\
(=1 if patient is on either Medicare or Medicaid)       &     Before Entry of Generic&     30480 &      .248\\
                                                        &     After Entry of Generic&      44793 &      .28\\
[1em]
\textbf{NonWhite}                                                &     Entire Study&             61442&      .164\\
(=1 if patient is a race other than white)                &     Before Entry of Generic&     37733&      .16\\
                                                        &     After Entry of Generic&      23709&      .171\\
\hline
$\text{Sample Size for Years 2006-2016} = 399245$\\
$\text{Before Entry of Generic} = 230182$\\
$\text{After Entry of Generic} = 169063$\\
\hline\hline
\multicolumn{4}{l}{\footnotesize All observations after July 2012 are considered to be after entry of generic.}\\
\end{tabular}

%multicolumn{5}{l}{"Share of Sample" and "Proportion Prescribed ST" are both weighted proportions}\\
%\multicolumn{5}{l}{offLabel(=1) indicates no diagnoses made were on label indicators, govInsurance(=1) indicates patient is on Medicare or Medicaid,}\\
%\multicolumn{5}{l}{nonWhite(=1) indicates patient is race other than white}\\
%\end{tabular}
%\label{tab:Table4.2}
%\end{table}
